Seoul, South Korea

Sung Jin Min

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Cellartgen Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sung Jin Min in Organoid Technology

Introduction

Sung Jin Min is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of organoid technology, particularly through his innovative patent that focuses on organ extracellular matrix-derived scaffolds. His work aims to enhance the culture and transplantation of organoids, which are miniature, simplified versions of organs.

Latest Patents

Sung Jin Min holds a patent for an "Organ extracellular matrix-derived scaffold for culture and transplantation of organoid and method of preparing the same." This patent describes a scaffold composition that includes an organ extracellular matrix, with the organ selected from the intestine, stomach, liver, and lung. The preparation of this scaffold involves decellularizing isolated organ tissue to create a decellularized organ tissue, drying it to form an organ extracellular matrix, and gelating the dried matrix. The patent also outlines the process of culturing an organoid within this scaffold composition.

Career Highlights

Sung Jin Min is currently associated with Cellartgen Inc., where he continues to advance research in organoid technology. His work is pivotal in developing methods that could potentially revolutionize organ transplantation and regenerative medicine.

Collaborations

Sung Jin Min collaborates with talented individuals such as Yi Sun Choi and Su Ran Kim, who contribute to the innovative projects at Cellartgen Inc. Their combined expertise fosters a collaborative environment that enhances research outcomes.

Conclusion

Sung Jin Min's contributions to organoid technology through his innovative patent and collaborative efforts position him as a key figure in the field. His work has the potential to significantly impact organ transplantation and regenerative medicine in the future.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…